Executive Medical Director in London

Our team is passionate in the pursuit of excellence and in pushing the boundaries of cancer therapy and autoimmune disease to deliver life-changing treatments to patients. Whilst working at Autolus you will enjoy a flexible, diverse, and dynamic working environment which actively promotes creativity, leadership, and teamwork.

Autolus is a biopharmaceutical company, advancing innovative therapies at both clinical and commercial stages of development, focused on next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the company is engineering precisely targeted, controlled, and highly active T cell therapies designed to better recognize cancer cells, break down their defence mechanisms, and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of haematological malignancies, solid tumours, and autoimmune diseases.

Autolus is developing complex, breakthrough therapies for a globally diverse market and equally recognises that diversity amongst our people is critical to our mission. As we draw on our differences, what we’ve experienced, and how we work, we celebrate diversity and are committed to creating an inclusive environment for all employees.

Role Summary

The Executive Medical Director (EMD) will be responsible for building and directing the United Kingdom Medical Affairs (MA) strategy for a product or group of products, as well as developing and implementing the overall Medical Affairs strategy for the dedicated Autolus products. The EMD will lead the implementation of the MA strategy including, but not limited to, scientific communications, oversight of all external publications, congress planning, Key Opinion Leader (KOL) engagement, advisory boards, and Investigator Initiated Trials (IIT) within the United Kingdom.

The EMD will focus on optimizing patient access and outcomes by providing up-to-date compound and disease area medical expertise, acting as a key expert in the relevant therapeutic area, and leading across functions to address external and internal stakeholder needs. The EMD will play a key role in developing and fostering relationships with KOLs, academic, institutional, and governmental authorities in collaboration with the commercial organization and provide scientific and medical support to patients’ organizations, lead evidence-based patient research and health economic outcomes research (HEOR), and be responsible for data dissemination, including presentations, publications, and scientific components of educational material and programs. The EMD will be the final signatory on all promotional materials.

Key Responsibilities

• Establish and lead the Medical Affairs for specific product(s) to provide strategic medical input to support pre-, peri- and post-launch activities.
• Support commercial business plans, including product communications, and final signatory for all promotional materials and activities.
• Develop and maintain the relevant KOL and other HCP relationships.
• Develop a KOL/advisor network to leverage opportunities for the product portfolio.
• Ensure regular contact as required with the UK and Ireland KOLs by the medical affairs team.
• Leverage KOLs to support non-promotional brand activities including market access, educational programs, and publications.
• Speaker decks for P2P meetings are reviewed and approved by the medical team in accordance with IPHA codes as appropriate.
• Collaborate with market access team to facilitate national and local reimbursement.
• Ensure all employees in the UK and Ireland have the appropriate level of scientific knowledge.
• Develop economic valuation and health outcomes research studies.
• Develop and execute the medical communications plan in close coordination with Global medical affairs and the commercial organization.
• Represent medical affairs at relevant UK, IRL and EU/Global Meetings and communicate outputs, engage with internal and external stakeholders.
• Provide Quality Systems support for any activities which are connected to impact/investigation assessments for cell collection centres.
• Establish scientific communication with KOLs and Scientific Health authorities.
• Lead the development and management of Medical Affairs SOPs.
• Develop and implement country medical plan.
• In collaboration with UK management team develop brand plans incorporating medical activities.
• Maintain a high level of knowledge and appropriately implement current local pharmaceutical regulation, ensure implementation of Autolus policies and procedures, and enhance cross-functional understanding of compliance requirements.
• Manage compliance of promotional materials with necessary regulations such as Blue Book, Human Medicines regulations 2012, PAGB code, IPHA Code and Statutory requirements.
• Be the final Medical Signatory for materials, in compliance with the IPHA code and other regulations.
• Act as the point of contact for resolution of complex matters as needed.
• Support and partner on training activities to Commercial, Clinical Research Associates (CRAs), Clinical Study Managers (CSMs), etc.
• Support Drug Regulatory Affairs (DRA) team on regulatory documents, filing and health authorities’ interactions.
• The EMD will need to be present onsite in London on a weekly basis with flexibility of hybrid working from home office in the UK.

Demonstrated skills and competencies

E – Essential P – Preferred

• Solid industry experience in medical affairs in hematology, cell therapy or oncology.
• Experience in the design of real-world evidence protocols and conduct of clinical trials in hematology/oncology is a plus.
• Breadth of experience in the biotechnology or pharmaceutical industry in the United Kingdom (E).
• Track record of working cross-functionally on strategic planning, as well as creation of a Life Cycle Management plan (E).
• Experience with full lifecycle development and medical support of successfully marketed biotechnology or pharmaceutical products (E).
• Experience in hematology/oncology, gained through industry experience or with relevant specialty training in hematology or solid tumours (P).
• Experience developing and/or launching a new pharmaceutical product/biologic product, CAR-T experience is preferred (P).
• Breadth of knowledge on ABPI Code and UK regulatory environment.

Qualifications

• Degree in Bpharm.